2 options
Private Profits versus Public Policy : The Pharmaceutical Industry and the Canadian State / Joel Lexchin.
- Format:
- Book
- Author/Creator:
- Lexchin, Joel, Author.
- Language:
- English
- Subjects (All):
- Pharmaceutical industry--Government policy--Canada.
- Pharmaceutical industry.
- Drug development--Government policy--Canada.
- Drug development.
- Canada.
- Genre:
- Electronic books.
- Physical Description:
- 1 online resource (385 pages) : illustrations, charts, tables
- Place of Publication:
- Toronto : University of Toronto Press, [2018]
- Language Note:
- In English.
- Summary:
- "The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies' quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public's favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years."-- Provided by publisher.
- Contents:
- Introduction : why do we care about the pharmaceutical industry in Canada?
- (De)regulation through cooperation
- Biased testing, hidden results, and the regulation of clinical trials
- Approving new drugs : better or just more?
- Regulating promotion or licensing deception?
- Health Canada and drug safety : how safe are we?
- Is intellectual property a right?
- How revenue is generated : prices, volume, mix, and overall spending
- Who gets the value from research and development?
- Canada, the pharmaceutical industry, and access to medicines in the global south
- Courage, my friends; 'tis not too late to build a better world.
- Notes:
- Includes bibliographical references and index.
- Description based on online resource; title from PDF title page (publisher's Web site, viewed 21. Dez 2019)
- ISBN:
- 1-4426-1961-9
- 1-4426-1960-0
- OCLC:
- 959713789
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.